Controversy over newly approved Alzheimer’s drugBy Chronicle Editor | June 11, 2021 | General | No Comments 0 Flares Twitter 0 Facebook 0 Google+ 0 StumbleUpon 0 Pin It Share 0 LinkedIn 0 Reddit 0 0 Flares × The FDA accepted Biogen’s Aducanumab after its very own independent recommended that it be denied. 0 Flares Twitter 0 Facebook 0 Google+ 0 StumbleUpon 0 Pin It Share 0 LinkedIn 0 Reddit 0 0 Flares × Share this:Click to share on Facebook (Opens in new window)Click to share on X (Opens in new window) Related Posts Alzheimer’s at 39: Chris’ story No Comments | Dec 25, 2019 I have skin cancer No Comments | Oct 3, 2021 Qué es la diabetes No Comments | Nov 17, 2020 Caregiver Training: Agitation and Anxiety | UCLA Alzheimer’s and Dementia Care Program No Comments | Jun 20, 2020
